N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
Nigel Theobald, CEO of N4 Pharma PLC (N4P.L) Interview
Share Talk Bulletin Board Heroes, Tuesday 9th March 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 11th February 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Covid-19 Stock Special, Bulletin Board Heroes, Sunday 24th January 2021
Zak Mir highlights some of the covid-19 players on the small-cap London market and gives an overview in this video charting update.
Weekend Edition, Bulletin Board Heroes, Sunday 6th December 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 3rd December 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
N4 Pharma PLC (N4P.L) Formulation Work Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide the following update on its ongoing
Share Talk Bulletin Board Heroes, Wednesday 18th November 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Share Talk Weekly Stock Market News, Sunday 15th November 2020
Share Talk is proud to be hosting a Webinar with Amur Minerals on Wednesday, November 25, 2020 · 04:00:00 PM · London Time.
Pharma Special, Bulletin Board Heroes, Tuesday 10th November 2020
Zak Mir highlights some of the most followed pharmaceutical stocks on the small-cap London market and gives an overview in this video charting update.
TPI provides its latest research note on N4 Pharma plc (N4P.L).
N4P has announced its appointment of Nanomerics Limited (‘Nanomerics’) to investigate the potential utility of Nuvec® in cancer therapy.
